Article Details
Retrieved on: 2022-10-31 08:42:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Stride (NYSE:LRN – Get Rating) had its price objective lowered by Morgan Stanley from $47.00 to $43.00 in a research note issued to investors on ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here